NGP 555

DRUG2 trials

Sponsors

NeuroGenetic Pharmaceuticals Inc

Conditions

Alzheimer's Disease

Phase 1

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)

CompletedNCT02534480

NeuroGenetic Pharmaceuticals IncAlzheimer's Disease

Start: 2015-03-31End: 2015-11-30Updated: 2016-01-13

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)

CompletedNCT02537938

NeuroGenetic Pharmaceuticals IncAlzheimer's Disease

Start: 2016-01-31End: 2016-12-31Updated: 2017-03-29